Company intelligence
neoplas med GmbH
About neoplas med GmbH
neoplas med GmbH was founded in 2009 as a spin-off of the Leibniz Institute for Plasma Science and Technology e. V. (INP) in Greifswald, Germany. Based on the INP research into plasma medicine, the emerging company develops innovative products for medical applications. The first product developed on this basis is the CE-marked kINPen® MED atmospheric pressure plasmajet, the first internationally approved and marketed plasma jet for the treatment of chronic wounds and pathogen-induced skin disorders. It is the result of a long-lasting cooperation with the INP institute, the university hospital of Greifswald, Germany, the Charité hospital of Berlin, Germany, and various industrial partners.
Verified activity
Signals from neoplas med GmbH
3 published signals
Research & Knowledge
neoplas med GmbH published a document titled Innovation & Disruption Leaders Deutschland featuring Dr. Klaus Ruhnau and Ulrike Sailer explaining the kINPen® MED technology.
Reported by neoplas med GmbH
Research & Knowledge
neoplas med GmbH published a document titled Innovation & Disruption Leaders Deutschland featuring Dr. Klaus Ruhnau and Ulrike Sailer explaining the kINPen® MED technology.
Reported by Ulrike Sailer
Presence & Recognition
neoplas med GmbH visited the ANIMAL DERMATOLOGY GROUP, INC Pasadena team to see how kINPen VET is integrated into clinical practice.
Reported by Ulrike Sailer